Skip to main content

Closed

DSGN: Design Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-35.7%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio22.28×

Design Therapeutics, Inc.

DSGNNASDAQ Global Select·USD·Closed

Design Therapeutics, Inc.

DSGNNASDAQ·USD·Closed

$12.18

−3.49%

$12.18

−$0.44 (3.49%)

52W Range

62thpctl

Volume

0.66×avg

Mkt Cap

760.73MUSD

P/E

-10.2TTM

Div Yield

–ann

52W Range

62thpctl

Volume

0.66×avg

Market Cap

760.73MUSD

P/E Ratio

-10.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings